Paper · 21982925
Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth.
Kurthkoti K and 1 other. Mech Ageing Dev, 2012. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth. Papers, record 21982925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21982925
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Damage | Major topic |
| DNA Repair | Major topic |
| Macrophages | Major topic |
| Mycobacterium smegmatis | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Animals | |
| Anti-Bacterial Agents | |
| Cell Hypoxia | |
| Drug Resistance, Bacterial | |
| Gene Expression Regulation, Bacterial | |
| Genotype | |
| Humans | |
| Microbial Viability | |
| Mutation | |
| Phenotype | |
| Reactive Nitrogen Species | |
| Reactive Oxygen Species |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,233,271 | Mismatch uracil DNA glycosylase (Mug) is maintained in the Corynebacterium pseudotuberculosis genome and exhibits affinity for uracil but not other types of damage. | Genet Mol Biol | 2025 | https://conductscience.org/library/papers/40233271 | PubMed |
| 39,595,627 | Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595627 | PubMed |
| 39,565,350 | Genetic stability of Mycobacterium smegmatis under the stress of first-line antitubercular agents. | Elife | 2024 | https://conductscience.org/library/papers/39565350 | PubMed |
| 38,930,573 | Sulforaphane Inhibits Oxidative Stress and May Exert Anti-Pyroptotic Effects by Modulating NRF2/NLRP3 Signaling Pathway in Mycobacterium tuberculosis-Infected Macrophages. | Microorganisms | 2024 | https://conductscience.org/library/papers/38930573 | PubMed |
| 26,276,393 | Mycobacterium tuberculosis RecG protein but not RuvAB or RecA protein is efficient at remodeling the stalled replication forks: implications for multiple mechanisms of replication restart in mycobacteria. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26276393 | PubMed |
| 25,874,691 | Use of Mycobacterium smegmatis deficient in ADP-ribosyltransferase as surrogate for Mycobacterium tuberculosis in drug testing and mutation analysis. | PLoS One | 2015 | https://conductscience.org/library/papers/25874691 | PubMed |
| 25,578,955 | The BER necessities: the repair of DNA damage in human-adapted bacterial pathogens. | Nat Rev Microbiol | 2015 | https://conductscience.org/library/papers/25578955 | PubMed |
| 24,800,740 | Apurinic/apyrimidinic endonucleases of Mycobacterium tuberculosis protect against DNA damage but are dispensable for the growth of the pathogen in guinea pigs. | PLoS One | 2014 | https://conductscience.org/library/papers/24800740 | PubMed |
| 24,658,131 | Either non-homologous ends joining or homologous recombination is required to repair double-strand breaks in the genome of macrophage-internalized Mycobacterium tuberculosis. | PLoS One | 2014 | https://conductscience.org/library/papers/24658131 | PubMed |
| 23,564,173 | Biochemical and structural studies of the Mycobacterium tuberculosis O6-methylguanine methyltransferase and mutated variants. | J Bacteriol | 2013 | https://conductscience.org/library/papers/23564173 | PubMed |
1 to 10 of 12
See all 12 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21982925
GET https://conductscience.org/api/papers/v1/21982925/authors